FFA
ABBV icon

Fi3 Financial Advisors’s AbbVie ABBV Stock Holding History

Fi3 Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$395K Sell
1,814
-131
-7% -$29.1K 0.11% 100
2025
Q4 		$444K Sell
1,945
-59
-3% -$13.4K 0.14% 86
2025
Q3 		$464K Sell
2,004
-150
-7% -$30.5K 0.16% 62
2025
Q2 		$400K Buy
2,154
+51
+2% +$9.48K 0.14% 68
2025
Q1 		$441K Sell
2,103
-59
-3% -$11.5K 0.18% 52
2024
Q4 		$384K Buy
2,162
+4
+0.2% +$735 0.14% 58
2024
Q3 		$426K Sell
2,158
-614
-22% -$115K 0.17% 47
2024
Q2 		$476K Sell
2,772
-58
-2% -$9.61K 0.21% 38
2024
Q1 		$464K Buy
2,830
+122
+5% +$21K 0.21% 38
2023
Q4 		$420K Sell
2,708
-89
-3% -$13K 0.2% 46
2023
Q3 		$417K Buy
2,797
+282
+11% +$41.4K 0.22% 40
2023
Q2 		$339K Sell
2,515
-338
-12% -$49.6K 0.18% 44
2023
Q1 		$455K Buy
2,853
+149
+6% +$22.8K 0.24% 41
2022
Q4 		$437K Buy
2,704
+617
+30% +$94.6K 0.25% 39
2022
Q3 		$280K Buy
+2,087
New +$299K 0.26% 35

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fi3 Financial Advisors's ABBV Position: Q1 2026 in Review

Fi3 Financial Advisors reduced its AbbVie (ABBV) stake by 6.7% in Q1 2026, selling an estimated $29.1K and leaving 1,814 shares worth $395K. The position accounts for 0.11% of the portfolio, ranked #100.

Fi3 Financial Advisors first reported a position in ABBV in Q3 2022 and has held it in 15 quarters since. The position peaked at $476K in Q2 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Fi3 Financial Advisors held 1,814 shares of AbbVie worth $395K as of Q1 2026.
  • Fi3 Financial Advisors sold 131 AbbVie shares in Q1 2026, an estimated $29.1K.
  • AbbVie made up 0.11% of Fi3 Financial Advisors's portfolio in Q1 2026, its #100 holding.
  • Fi3 Financial Advisors first reported a position in AbbVie in Q3 2022 and has held it in 15 quarters since.
  • Fi3 Financial Advisors's AbbVie position peaked at $476K in Q2 2024.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Fi3 Financial Advisors's 13F filing for Q1 2026, filed 7 May 2026.